Literature DB >> 24852741

Severe spruelike enteropathy due to olmesartan.

Gioia Fiorucci, Efisio Puxeddu, Renato Colella, Gian Paolo Reboldi, Vincenzo Villanacci, Gabrio Bassotti.   

Abstract

Villous atrophy and negative serologic testing is a diagnostic challenge, and the rarer possibility of drug-induced enteritis should be considered. We report a rare case of severe spruelike enteritis due to olmesartan that completely resolved after withdrawal of the drug. The possibility that patient labeled as "refractory" celiac disease may actually be due to drug treatment should always be taken into consideration, to avoid unnecessary investigations.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24852741     DOI： 10.4321/s1130-01082014000200011

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN： 1130-0108            Impact factor:   2.086


  9 in total

1.  Immunopathogenesis of olmesartan-associated enteropathy.

Authors:  E V Marietta; A M Nadeau; A K Cartee; I Singh; A Rishi; R S Choung; T-T Wu; A Rubio-Tapia; J A Murray
Journal:  Aliment Pharmacol Ther       Date:  2015-10-01       Impact factor: 8.171

Review 2.  Microscopic enteritis: Bucharest consensus.

Authors:  Kamran Rostami; David Aldulaimi; Geoffrey Holmes; Matt W Johnson; Marie Robert; Amitabh Srivastava; Jean-François Fléjou; David S Sanders; Umberto Volta; Mohammad H Derakhshan; James J Going; Gabriel Becheanu; Carlo Catassi; Mihai Danciu; Luke Materacki; Kamran Ghafarzadegan; Sauid Ishaq; Mohammad Rostami-Nejad; A Salvador Peña; Gabrio Bassotti; Michael N Marsh; Vincenzo Villanacci
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

Review 3.  Association of sprue-like enteropathy and angiotensin receptor-1 antagonists.

Authors:  René R Wenzel; Christian Datz
Journal:  Wien Klin Wochenschr       Date:  2019-08-30       Impact factor: 1.704

4.  Olmesartan-induced enteropathy associated with cutaneous lesions.

Authors:  Nassim Hammoudi; Marie Dior; Vincent Giraud; Benoit Coffin
Journal:  Clin Case Rep       Date:  2016-03-02

5.  Olmesartan-Induced Enteropathy: An Unusual Cause of Villous Atrophy.

Authors:  Marta Eusébio; Paulo Caldeira; Artur Gião Antunes; André Ramos; Francisco Velasco; Jesús Cadillá; Horácio Guerreiro
Journal:  GE Port J Gastroenterol       Date:  2015-10-20

6.  Olmesartan-Induced Sprue Like Enteropathy.

Authors:  Liliana Carneiro; Albina Moreira; Adelina Pereira; Carina Andrade; José Soares; Artur Silva
Journal:  GE Port J Gastroenterol       Date:  2016-01-14

7.  Enteropathy Associated with Olmesartan.

Authors:  Bruno Moreira da Silva; Sofia Jardim Neves; Arantza Germade Martínez; Karina de Jesús Geneux; Jesús Lomas García; Sergio Maestro Antolín; Antonio Pérez Millán
Journal:  GE Port J Gastroenterol       Date:  2015-12-03

8.  Sprue-Like Enteropathy Associated With Olmesartan: A New Kid on the Enteropathy Block.

Authors:  Isabel A Hujoel; Alberto Rubio-Tapia
Journal:  GE Port J Gastroenterol       Date:  2016-03-28

9.  Severe intestinal malabsorption associated with ACE inhibitor or angiotensin receptor blocker treatment. An observational cohort study in Germany and Italy.

Authors:  Peter Malfertheiner; Claudio Ripellino; Nazarena Cataldo
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-02-19       Impact factor: 2.890
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.